Clinical Trials Browser

Phase 3 × INDUSTRY × ivosidenib × Clear all

NCT05876754 2026-02-19

ProvIDHe

Phase 3 Recruiting

Gastrointestinal

Cholangiocarcinoma

NCT06127407 2026-02-06

CHONQUER

Phase 3 Recruiting

Neoplasm Metastasis

NCT03173248 2025-11-10

AGILE

Phase 3 Active not recruiting

146 enrolled 11 charts 1 FDA

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT05907057 2025-04-11

An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02989857 2024-08-20

ClarIDHy

Phase 3 Completed

187 enrolled 34 charts 1 FDA

Gastrointestinal

Cholangiocarcinoma